Navigation Links
ACAAI and AGA Partner to Raise Awareness of Hereditary Angioedema Through 'HAE: Learn About It, Talk About It'

NEW ORLEANS, May 3 /PRNewswire/ -- The American College of Allergy, Asthma and Immunology (ACAAI) and the American Gastroenterological Association (AGA)Institute today announced an innovative initiative called "HAE:  Learn About It, Talk About It," at Digestive Disease Week® 2010.  The peer-driven campaign is designed to foster communication between physicians on the front lines of the diagnosis and treatment of hereditary angioedema (HAE), a rare and potentially fatal swelling disease.  

HAE is a genetic disease affecting between 6,000-15,000 people in the United States.  It is characterized by sudden, severe, and painful swelling that can affect any part of the body, including the extremities, face, gastrointestinal tract, urogenital tract and – most dangerously – the tongue or larynx.  Patients with HAE can experience frequent recurrences that can each last for a few days, with up to 100 days of incapacitation per year, making it challenging to excel in school and at work, and even participate in daily activities.  Due to the rarity and lack of awareness of HAE, and symptoms that can mimic other conditions, such as an allergic reaction, HAE is commonly misdiagnosed.  For some patients, it has taken up to 20 years and visits to a variety of physicians to reach the right diagnosis.  

"One-third of undiagnosed HAE patients have undergone exploratory surgery during an abdominal attack, and 70-80 percent of HAE patients experience recurrent abdominal symptoms.  These statistics underscore the importance of educational programs to raise awareness of the disease," said William J. Tremaine, M.D., AGA program advisor and Professor of Medicine at the Mayo Clinic. "Our hope is that, by collaborating on this innovative program, we can help educate gastroenterologists to work with allergists and immunologists to improve the rate of accurate and timely diagnosis of HAE and, therefore, patient care."

"This is an exciting partnership, bringing together two specialties to work towards relieving patient suffering," said Sami Bahna, M.D., DrPH, Chief of Allergy and Immunology at Louisiana State University Health Sciences Center in Shreveport, and President of ACAAI.  "While allergists and immunologists are experts in the diagnosis and treatment of HAE, they truly need the support and dialogue with general practitioners, emergency medicine physicians, gastroenterologists, and other specialists to ensure HAE patients are getting appropriate treatment."

"With new, approved treatment options available, there is more reason than ever for doctors to know about HAE," said Dr. Jonathan Bernstein, ACAAI program advisor and Professor of Medicine, Department of Internal Medicine, Division of Immunology/Allergy at the University of Cincinnati.


The core component of "HAE: Learn About It, Talk About It" is an informational and interactive Web site – – which provides physicians with the tools they need to more readily diagnose symptoms and treat HAE appropriately, including a diagnostic checklist and case studies.  A Webinar on Thursday, June 3, presented by Dr. Jonathan Bernstein and Dr. William Tremaine, will provide physicians with an opportunity to learn more about identifying, diagnosing, and treating HAE.  For more information, including how to register for the Webinar, visit  

"HAE:  Learn About It, Talk About It" is a joint effort of the American College of Asthma, Allergy and Immunology (ACAAI) and the American Gastroenterological Association (AGA) Institute and supported by ViroPharma Incorporated.  Because the effects of HAE on patients and the medical community are significant, with attacks often mistaken by both physicians and patients for serious allergic reactions or abdominal surgical emergencies, "HAE:  Learn About It, Talk About It" will be expanded in the coming months to include other medical specialties that may come into contact with patients with HAE.


The ACAAI is a professional medical organization headquartered in Arlington Heights, Ill., that promotes excellence in the practice of the subspecialty of allergy and immunology.  The College, comprising more than 5,000 allergists-immunologists and related health care professionals, fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research.  To learn more about allergies and asthma and to find an allergist, visit

About the AGA Institute

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization.

SOURCE The American College of Allergy, Asthma and Immunology; American Gastroenterological Association
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009
4. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
5. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
6. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
10. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
11. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
Post Your Comments:
(Date:12/1/2015)... 2015  CardioCell LLC, a Stemedica Cell Technologies ... cardiovascular indications, intends to proceed with finalizing a ... from a Heart Failure Advisory Board comprising cardiology ... Board members . In a recent meeting members ... and efficacy data from CardioCell,s on-going chronic heart ...
(Date:12/1/2015)... 1, 2015 Cepheid (Nasdaq: CPHD ) ... the Piper Jaffray Healthcare Conference in New ... is reaffirming its outlook for the fourth quarter of ... to discussing longer term business model expectations. ...  "We continue to be the fastest growing company of ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... physicians, aesthetic practitioners and aesthetics professionals from Central America and abroad for the ... in Panama City, Panama Feb. 17-19, 2016. Testart will present and discuss new ...
(Date:11/30/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a leader in ... Business Act on Climate Pledge, alongside more than 140 companies ... Obama Administration to demonstrate an ongoing commitment to climate action ... COP21 Paris climate negotiations. ... Canada . --> BioAmber uses biotechnology to ...
Breaking Biology Technology:
(Date:11/12/2015)... Nov. 12, 2015  Arxspan has entered into ... and Harvard for use of its ArxLab cloud-based ... tools. The partnership will support the institute,s efforts ... chemical research information internally and with external collaborators. ... for managing the Institute,s electronic laboratory notebook, compound ...
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
Breaking Biology News(10 mins):